1.
Serum prolidase, urotensin-2 and nesfatin levels in patients with compensated or uncompensated cirrhosis (Annals of Medical Research, 2019;26(8):1666-1669). Ann Med Res [Internet]. 2024 Sep. 26 [cited 2025 Apr. 4];31(9):757. Available from: http://annalsmedres.org/index.php/aomr/article/view/4734